H. L. Surratt, T. J. Cicero, M. W. Parrino, S. G. Severtson, B. Bucher-bartelson et al., Trends in opioid analgesic abuse and mortality in the United States, United Nations Office on Drugs and Crime, vol.372, issue.3, pp.241-249, 2007.

, Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence, p.39, 2009.

L. Karila, I. Berlin, A. Benyamina, and M. Reynaud, Psychotic symptoms following buprenorphine withdrawal, Am J Psychiatry, vol.165, issue.3, pp.400-401, 2008.

G. F. Koob and N. D. Volkow, Neurocircuitry of addiction, Neuropsychopharmacology, vol.35, issue.1, pp.217-255, 2010.

J. E. Powell and D. Taylor, Anger, depression, and anxiety following heroin withdrawal, Int J Addict, vol.27, issue.1, pp.25-35, 1992.
DOI : 10.3109/10826089109063460

I. Elman, D. 'ambra, M. N. Krause, S. Breiter, H. Kane et al., Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes, Drug Alcohol Depend, vol.61, p.163, 2001.
DOI : 10.1016/s0376-8716(00)00139-3

T. Suzuki, M. Tsuda, M. Narita, M. Funada, H. Mizoguchi et al., Diazepam pretreatment suppresses morphine withdrawal signs in the mouse, Life Sci, vol.58, p.349, 1996.

B. M. Radvansky, K. Shah, A. Parikh, A. N. Sifonios, V. Le et al., Role of ketamine in acute postoperative pain management: a narrative review, Biomed Res Int, vol.749837, 2015.

R. Griffiths, Opioid-induced hyperalgesia: low-dose ketamine does work for some orthopaedic problems already, Br J Anaesth, vol.104, issue.5, pp.660-661, 2010.
DOI : 10.1093/bja/aeq075

J. P. Laulin, P. Maurette, J. B. Corcuff, C. Rivat, M. Chauvin et al., The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance, Anesth Analg, vol.94, issue.5, pp.1263-1272, 2002.

E. Visser and S. A. Schug, The role of ketamine in pain management, Biomed Pharmacother, vol.60, issue.7, pp.341-349, 2006.

R. F. Bell, Ketamine for chronic non-cancer pain, Pain, vol.141, issue.3, pp.210-214, 2009.
DOI : 10.1016/j.pain.2008.12.003

M. Niesters, C. Martini, and A. Dahan, Ketamine for chronic pain: risks and benefits, Br J Clin Pharmacol, vol.77, issue.2, pp.357-67, 2014.
DOI : 10.1111/bcp.12094
URL : https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12094

M. I. Blonk, B. G. Koder, P. M. Van-den-bemt, and F. J. Huygen, Use of oral ketamine in chronic pain management: a review, Eur J Pain, vol.14, issue.5, pp.466-72, 2010.

K. Raith and G. Hochhaus, Drugs used in the treatment of opioid tolerance and physical dependence: a review, Int J Clin Pharmacol Ther, vol.42, issue.4, pp.191-203, 2004.

R. N. Jamison and J. Mao, Opioid Analgesics, Mayo Clin Proc, vol.90, issue.7, pp.957-68, 2015.

L. F. Chu, D. J. Clark, and M. S. Angst, Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study, J Pain, vol.7, issue.1, pp.43-51, 2006.

M. Lee, S. M. Silverman, H. Hansen, V. B. Patel, and L. Manchikanti, A comprehensive review of opioid-induced hyperalgesia, Pain Physician, vol.14, issue.2, pp.145-61, 2011.

S. Mercadante, Ketamine in cancer pain: an update, Palliat Med, vol.10, issue.3, pp.225-255, 1996.

R. Kohrs and M. E. Durieux, Ketamine: Teaching an old drug new tricks, Anesth Analg, vol.87, issue.5, pp.1186-93, 1998.

R. F. Bell, J. B. Dahl, R. A. Moore, and E. A. Kalso, Perioperative ketamine for acute postoperative pain. Pain, Palliative and Supportive Care Group, Cochrane Database Syst Rev, vol.49, issue.10, pp.1405-1433, 2005.

N. D. Iadarola, M. J. Niciu, E. M. Richards, V. Voort, J. L. Ballard et al., Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review, Ther Adv Chronic Dis, vol.6, issue.3, pp.97-114, 2015.

F. Aroni, N. Iacovidou, I. Dontas, C. Pourzitaki, and T. Xanthos, Pharmacological aspects and potential new clinical applications of ketamine: Reevaluation of an old drug, J Clin Pharmacol, vol.49, issue.8, pp.957-64, 2009.

A. R. Powers-3rd, M. G. Gancsos, E. S. Finn, P. T. Morgan, and P. R. Corlett, KetamineInduced Hallucinations, Psychopathology, vol.48, issue.6, pp.376-85, 2015.

N. Delimbeuf, A. Petit, L. Karila, and M. Lejoyeux, Ketamine: psychiatric indications and misuses, Rev Med Liege, vol.69, issue.7-8, pp.434-474, 2014.

J. X. Liu, E. Zerbo, and S. Ross, Intensive ketamine use for multiple years: A case report, Am J Addict, vol.24, issue.1, pp.7-9, 2015.

T. Jovaisa, G. Laurinenas, S. Vosylius, J. Sipylaite, R. Badaras et al., Effects of ketamine on precipitated opiate withdrawal, Medicina (Kaunas), vol.42, issue.8, pp.625-659, 2006.

H. Ito, K. Sobue, H. Hirate, T. Sugiura, M. So et al., Use of ketamine to facilitate opioid withdrawal in a child, Anesthesiology, vol.104, issue.5, p.1113, 2006.

J. Gagnier, G. Kienle, D. G. Altman, D. Moher, H. Sox et al., The CARE guidelines: consensus-based clinical case report guideline development, J Clin Epidemiol, vol.67, issue.1, pp.46-51, 2013.

, Diagnostic and Statistical Manual of Mental Disorders, 2013.

J. Streltzer, R. Davidson, and D. Goebert, An observational study of buprenorphine treatment of the prescription opioid dependent pain patient, Am J Addict, vol.24, issue.4, pp.357-61, 2015.

D. T. Barry, J. D. Savant, M. Beitel, C. J. Cutter, B. A. Moore et al., Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone, J Addict Med, vol.6, issue.4, pp.274-283, 2012.

C. J. Morgan and H. V. Curran, Independent Scientific Committee on Drugs, Addiction, vol.107, issue.1, pp.27-38, 2012.